“cormorant-asset-management” Archives

in
Entry Author Date Location
Twist Bioscience Garners $61,000,000 Series D Financing 01/19/16 San Francisco
With Tensha Purchase, Roche Interest in Bradner Startups Continues 01/11/16 Boston
Iconic Therapeutics Secures $40,000,000 Series C Financing Round 01/11/16 San Francisco
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
C4 Therapeutics Lands $73,000,000 Series A Round 01/08/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
Scholar Rock Lands $36,000,000 Series B Financing Round 01/04/16 Boston
Axonics Modulation Technologies Garners $38,500,000 Series B Funding 12/21/15 San Diego
Months After Postponed IPO, Gelesis Nabs $31.5M And a New Investor 12/18/15 Boston
Gelesis Garners $31,500,000 New Financing Round 12/18/15 Boston
ImmuneXcite Garners $8,600,000 Series A Financing Round 12/11/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
Corvus Pharmaceuticals Receives $75,000,000 Series B Funding 09/30/15 San Francisco
Proteostasis Therapeutics Lands $37,000,000 Series B Funding 09/09/15 Boston
At Summer’s End, Can Crossover Winds Stay At Biotech’s Back? 09/01/15 National
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
Syndax Pharmaceuticals Garners $80,000,000 New Financing 08/24/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
WAVE Life Sciences Garners $66,000,000 Series B Funding 08/18/15 Boston
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
AnaptysBio Receives $40,000,000 Series D Funding 07/16/15 San Diego
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Page 2 of 2 « previous page